Catalyst

Slingshot members are tracking this event:

$10MM Milestone Given to Cempra (CEMP) After Toyama (FUJIY) Advances Respiratory Tract Infection Treatment Solithromycin to Phase 3 Testing in Japan

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CEMP

100%
FUJIY

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 01, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Milestone Payment, Respiratory Tract Infection, Solithromycin, Phase 3